Zheng YF - Search Results

1

Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales.

Fan L, Li Y, Chen JY, Zheng YF, Xu XM. Fan L, et al. Among authors: zheng yf. Cancer Lett. 2019 Aug 1;456:23-28. doi: 10.1016/j.canlet.2019.03.050. Epub 2019 Apr 5. Cancer Lett. 2019. PMID: 30959079 Review.

2

Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells.

Zhang L, Ge W, Hu K, Zhang Y, Li C, Xu X, He D, Zhao Z, Zhang J, Jie F, Chen Y, Zheng Y. Zhang L, et al. Mol Biol Rep. 2012 Jan;39(1):89-95. doi: 10.1007/s11033-011-0713-6. Epub 2011 May 13. Mol Biol Rep. 2012. PMID: 21567206

3

Endostar enhances the antitumor effects of radiation by affecting energy metabolism and alleviating the tumor microenvironment in a Lewis lung carcinoma mouse model.

Zheng YF, Ge W, Xu HL, Cao DD, Liu L, Ming PP, Li CH, Xu XM, Tao WP, Tao ZZ. Zheng YF, et al. Oncol Lett. 2015 Nov;10(5):3067-3072. doi: 10.3892/ol.2015.3679. Epub 2015 Sep 7. Oncol Lett. 2015. PMID: 26722291 Free PMC article.

4

Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.

He X, Zheng Y, Zhang Y, Gan Y, Zhou Y, Liang H, Wu D, Ge W, Deng J, Xu X. He X, et al. Oncotarget. 2017 Feb 7;8(6):9451-9465. doi: 10.18632/oncotarget.14276. Oncotarget. 2017. PMID: 28035067 Free PMC article.

5

High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.

He XQ, Zhang YF, Yu JJ, Gan YY, Han NN, Zhang MX, Ge W, Deng JJ, Zheng YF, Xu XM. He XQ, et al. Among authors: zheng yf. Tumour Biol. 2017 Mar;39(3):1010428317695971. doi: 10.1177/1010428317695971. Tumour Biol. 2017. PMID: 28347229 Free article.

6

Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.

Cao DD, Xu HL, Liu L, Zheng YF, Gao SF, Xu XM, Ge W. Cao DD, et al. Among authors: zheng yf. Oncotarget. 2017 Jul 4;8(27):44976-44993. doi: 10.18632/oncotarget.16689. Oncotarget. 2017. PMID: 28402958 Free PMC article. Review.

7

Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma.

Gan Y, Han N, He X, Yu J, Zhang M, Zhou Y, Liang H, Deng J, Zheng Y, Ge W, Long Z, Xu X. Gan Y, et al. Tumour Biol. 2017 Jun;39(6):1010428317706229. doi: 10.1177/1010428317706229. Tumour Biol. 2017. PMID: 28621238 Free article.

8

The extracellular vesicles secreted by lung cancer cells in radiation therapy promote endothelial cell angiogenesis by transferring miR-23a.

Zheng Y, Liu L, Chen C, Ming P, Huang Q, Li C, Cao D, Xu X, Ge W. Zheng Y, et al. PeerJ. 2017 Aug 25;5:e3627. doi: 10.7717/peerj.3627. eCollection 2017. PeerJ. 2017. PMID: 28852584 Free PMC article.

9

Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma.

Weng Q, Chen M, Li M, Zheng YF, Shao G, Fan W, Xu XM, Ji J. Weng Q, et al. Among authors: zheng yf. J Med Genet. 2019 Jan;56(1):32-38. doi: 10.1136/jmedgenet-2018-105440. Epub 2018 Aug 17. J Med Genet. 2019. PMID: 30120213

10

Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions.

Yan YF, Zheng YF, Ming PP, Deng XX, Ge W, Wu YG. Yan YF, et al. Among authors: zheng yf. Brief Funct Genomics. 2019 Mar 22;18(2):147-156. doi: 10.1093/bfgp/ely029. Brief Funct Genomics. 2019. PMID: 30247518 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters